Bargains! PROMOTIONS

Close Notification

Your cart does not contain any items

CRISPR-Cas9 Technology for Precision Medicine

Jen-Tsung Chen

$577.95   $462.48

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Igi Global Scientific Publishing
07 January 2026
CRISPR-Cas9 technology emerges as one of the most powerful tools in modern biomedical science, offering precision in genetic and genomic editing. By enabling targeted modifications to DNA with accuracy, CRISPR-Cas9 unveils a new era of precision medicine in which treatments are tailored to the genetic makeup of individual patients. This technology corrects disease-causing mutations, engineers patient-specific therapies, and creates safer, more effective interventions across a wide range of genetic and complex diseases. As research advances, CRISPR-Cas9 continues to redefine applications in personalized healthcare. CRISPR-Cas9 Technology for Precision Medicine explores how CRISPR-Cas9 enables highly targeted and efficient genome editing to support personalized approaches to disease prevention, diagnosis, and treatment. It examines the potential of technology to correct genetic mutations, develop individualized therapies, and transform precision medicine. This book covers topics such as medical therapeutics, oncology, and genetic editing, and is a useful resource for medical and healthcare professionals, geneticists, academicians, researchers, and scientists.
Edited by:  
Imprint:   Igi Global Scientific Publishing
Dimensions:   Height: 254mm,  Width: 178mm,  Spine: 27mm
Weight:   1.061kg
ISBN:   9798337348575
Pages:   500
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Hardback
Publisher's Status:   Active

Jen-Tsung Chen is a professor of cell biology at the National University of Kaohsiung in Taiwan. He also teaches genomics, proteomics, plant physiology, and plant biotechnology. Dr. Chen's research interests include bioactive compounds, chromatography techniques, plant molecular biology, plant biotechnology, bioinformatics, and systems pharmacology. He is an active editor of academic books and journals to advance the exploration of multidisciplinary knowledge involving plant physiology, plant biotechnology, nanotechnology, ethnopharmacology, systems biology, and drug discovery. He serves as an editorial board member and a guest editor in several reputed journals. Dr. Chen published books in collaboration with international publishers on diverse topics such as drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR-based plant genome editing, and artificial intelligence. In 2023 and 2024, Elsevier and Stanford University recognized Dr. Chen as one of the ""World's Top 2% Scientists"".

See Also